Evaluation of the pharmacokinetics and food intake effect of generic sofosbuvir in healthy Chinese subjects

被引:3
|
作者
Li, Xin [1 ]
Liu, Yujie [2 ]
Xu, Bing [1 ]
Liu, Lihua [1 ]
Li, Yuan [1 ]
Zhang, Ping [3 ]
机构
[1] Third Hosp Changsha, Dept Pharm, Changsha, Hunan, Peoples R China
[2] Nanjing Chia Tai Tianqing Pharmaceut Co Ltd, Nanjing, Jiangsu, Peoples R China
[3] Nanjing Clin Tech Labs Inc, Nanjing, Jiangsu, Peoples R China
关键词
generic sofosbuvir; pharmacokinetics; food effect; hepatitis C; healthy Chinese; HEPATITIS-C VIRUS; POLYMERASE INHIBITOR; INFECTION;
D O I
10.5414/CP203649
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Sofosbuvir is an NS5B nucleotide inhibitor that was approved for hepatitis C treatment. Generic sofosbuvir has been produced to improve the affordability. The present study investigated the pharmacokinetics (PK) and safety of generic sofosbuvir as well as the effect of food intake on its PK parameters in healthy Chinese subjects. Materials and methods: This open-label, randomized, multiple-dose, dose-escalating, and food effect trial enrolled 12 healthy Chinese subjects. The subjects received a single oral dose of 400 mg of generic sofosbuvir in fasted state or after a high-fat meal. or 800 mg in fasted state, in a three-way crossover design, and then all subjects were administered with 400 mg daily for 8 days. The PK parameters for sofosbuvir and its metabolites were determined, and the safety was monitored. Results: Sofosbuvir was absorbed rapidly into plasma. with a half-life of 0.46 - 0.48 hours. Plasma exposure to sofosbuvir and its metabolite GS-566500 was increased in an approximately proportional manner to the increased dose. Repeated dosing did not result in drug accumulation in the blood. Sofosbuvir was mainly excreted as the metabolite GS-331007 in the urine. Drug administration after a high-fat meal increased the plasma sofosbuvir exposure by 1.29-fold, without substantially altering the absorption rate. No serious adverse events were observed, and all subjects tolerated the doses well. Conclusion: This generic sofosbuvir was well absorbed, the plasma concentration was increased with an increased dose. and it was safe in healthy subjects. A high-fat meal appeared to promote the bioavailability of sofosbuvir and the metabolite GS-566500. What is known about this subject - Pharmacokinetics of single and multiple dose (400 mg) brand-name sofosbuvir in healthy Chinese subjects under fasting conditions have been studied. What this study adds - This study evaluated the pharmacokinetic profile of generic sofosbuvir in healthy Chinese subjects. - This generic sofosbuvir was well absorbed, and the plasma concentration was increased with an increased dose. A high-fat meal appeared to promote the bioavailability of this drug and the metabolite GS-566500. - Sofosbuvir at doses up to 800 mg was well tolerated.
引用
收藏
页码:230 / 241
页数:12
相关论文
共 50 条
  • [21] Evaluation of Food Effect on the Pharmacokinetics of Velufenacin, a New Muscarinic Receptor Antagonist, in Healthy Subjects
    Khwarg, Juyoung
    Chung, Woo Kyung
    Lee, Soyoung
    Yang, Eunsol
    Ryu, Chaelim
    Lee, Dae Young
    Lee, Min Jung
    Jang, In-Jin
    Yu, Kyung-Sang
    Lee, Seunghwan
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (02): : 128 - 133
  • [22] The Effect of Food Intake on the Pharmacokinetics of Oral Basal Insulin: A Randomised Crossover Trial in Healthy Male Subjects
    Inge B. Halberg
    Karsten Lyby
    Karsten Wassermann
    Tim Heise
    Leona Plum-Mörschel
    Eric Zijlstra
    Clinical Pharmacokinetics, 2019, 58 : 1497 - 1504
  • [23] Pharmacokinetic Profile of a Generic Formulation of Sofosbuvir and Its Metabolite GS-331007 in Healthy Chinese Subjects
    Shen, Zhenwei
    Zhu, Xiaoxue
    Zhang, Hong
    Chen, Hong
    Niu, Junqi
    Chen, Guiling
    Li, Xiaojiao
    Ding, Yanhua
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (08): : 1073 - 1080
  • [24] The Effect of Food Intake on the Pharmacokinetics of Oral Basal Insulin: A Randomised Crossover Trial in Healthy Male Subjects
    Halberg, Inge B.
    Lyby, Karsten
    Wassermann, Karsten
    Heise, Tim
    Plum-Moerschel, Leona
    Zijlstra, Eric
    CLINICAL PHARMACOKINETICS, 2019, 58 (11) : 1497 - 1504
  • [25] Effect of mushroom diet on pharmacokinetics of gabapentin in healthy Chinese subjects
    Toh, Dorothy Su Lin
    Limenta, Lie Michael George
    Yee, Jie Yin
    Wang, Ling-Zhi
    Goh, Boon-Cher
    Murray, Michael
    Lee, Edmund Jon Deoon
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (01) : 129 - 134
  • [26] Effect of CAR polymorphism on the pharmacokinetics of artemisinin in healthy Chinese subjects
    Zang, Meitong
    Zhao, Lixia
    Zhu, Fanping
    Li, Xinxiu
    Yang, Aijuan
    Xing, Jie
    DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (01) : 123 - 126
  • [27] Unexpected Effect of Evacetrapib on Simvastatin Pharmacokinetics in Healthy Chinese Subjects
    Liang, Yan
    Cui, Yimin
    Cannady, Ellen A.
    Small, David S.
    Xin, Ping
    Wang, Ming-Dauh
    Jin, Jian Jun
    Zhao, Xia
    Suico, Jeffrey G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C129 - C129
  • [28] Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects
    Khosravan, Reza
    Grabowski, Brian
    Wu, Jing-Tao
    Joseph-Ridge, Nancy
    Vernillet, Laurent
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 (03) : 355 - 363
  • [29] The Effect of Rifampin on the Pharmacokinetics of Sofosbuvir in Healthy Volunteers
    Garrison, Kimberly L.
    Wang, Yi
    Brainard, Diana M.
    Sajwani, Karim
    Mathias, Anita
    HEPATOLOGY, 2014, 60 : 682A - 682A
  • [30] The pharmacokinetics of lamivudine in healthy Chinese subjects
    Jiang, J
    Hu, P
    Xie, H
    Chen, H
    Fan, F
    Harker, A
    Johnson, MA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (02) : 250 - 253